DERMAL LABORATORIES LIMITED
Get an alert when DERMAL LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-02-28 (in 9mo)
Last filed for 2025-05-31
Confirmation statement due
2027-01-06 (in 8mo)
Last made up 2025-12-23
Watchouts
None on the register
Cash
£7M
+1.6% vs 2024
Net assets
£45M
+5.6% highest in 6 filed years
Employees
171
+1.8% highest in 6 filed years
Profit before tax
£2M
+66.4% highest in 6 filed years
Net assets
10-year trend · vs Health Care median
Accounts
10-year trend · latest reflected 2025-05-31
| Metric | Trend | 2020-05-31 | 2020-06-01 | 2021-05-31 | 2021-06-01 | 2022-05-31 | 2022-06-01 | 2023-05-31 | 2023-06-01 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | £37,840,958 | — | £38,307,969 | — | £39,098,984 | — | £38,451,546 | — | £42,124,318 | £45,713,215 | |
| Operating profit | £2,184,881 | — | £2,013,875 | — | £1,495,236 | — | £512,747 | — | £1,345,742 | £2,164,066 | |
| Profit before tax | £2,216,042 | — | £2,013,632 | — | £1,495,229 | — | £511,919 | — | £1,429,801 | £2,378,917 | |
| Net profit | £3,231,844 | — | £2,894,941 | — | £1,979,689 | — | £892,370 | — | £1,429,801 | £2,378,917 | |
| Cash | £9,684,193 | — | £7,376,506 | — | £7,233,714 | — | £7,037,078 | — | £6,427,385 | £6,527,581 | |
| Total assets less current liabilities | £36,242,762 | — | £39,281,879 | — | £40,322,913 | — | £40,834,832 | — | £42,264,633 | £44,643,550 | |
| Net assets | £35,898,416 | — | £38,793,357 | — | £39,942,462 | — | £40,834,832 | — | £42,264,633 | £44,643,550 | |
| Equity | £35,898,416 | £35,898,416 | £38,793,357 | £38,793,357 | £39,942,462 | £39,942,462 | £40,834,832 | £40,834,832 | £42,264,633 | £44,643,550 | |
| Average employees | 161 | — | 160 | — | 166 | — | 170 | — | 168 | 171 | |
| Wages | £8,043,605 | — | £8,840,441 | — | £8,794,632 | — | £10,329,372 | — | £9,256,237 | £9,792,843 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-05-31 | 2020-06-01 | 2021-05-31 | 2021-06-01 | 2022-05-31 | 2022-06-01 | 2023-05-31 | 2023-06-01 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 5.8% | — | 5.3% | — | 3.8% | — | 1.3% | — | 3.2% | 4.7% | |
| Net margin | 8.5% | — | 7.6% | — | 5.1% | — | 2.3% | — | 3.4% | 5.2% | |
| Return on capital employed | 6.0% | — | 5.1% | — | 3.7% | — | 1.3% | — | 3.2% | 4.8% | |
| Current ratio | — | — | — | — | — | — | — | — | 4.74x | 5.02x | |
| Interest cover | — | — | 383.01x | — | 213605.14x | — | 266.36x | — | 3522.88x | 4090.86x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Haslers
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “During the year the company paid for third party indemnity insurance on behalf of the director.”
- “Since the balance sheet date, there have been no events requiring adjustment to the financial statements. The Board continues to monitor the wider economic and political environment following the change of government in July 2024, and any new measures introduced will be assessed for their potential impact on the business.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| YARROW, Michael Jonathan | Director | — | Dec 1947 | British |
| YARROW, Nicola Irene | Director | 2023-09-20 | Nov 1987 | British |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HEAD, Andrew James | Secretary | 2007-09-28 | 2024-01-12 |
| O'CARROLL, Teresa | Secretary | — | 2007-09-28 |
| MITCHELSON, Ian Geoffrey | Director | — | 2014-08-29 |
| WHITEFIELD, Martin, Dr | Director | — | 2002-12-09 |
| YARROW, Hyman, Dr | Director | — | 2005-12-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Diomed Developments Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 101 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-25 | AA | accounts | Accounts with accounts type full | |
| 2026-01-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-02-28 | AA | accounts | Accounts with accounts type full | |
| 2025-01-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-02-27 | AA | accounts | Accounts with accounts type full | |
| 2024-01-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-01-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-09-21 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-23 | AA | accounts | Accounts with accounts type full | |
| 2023-01-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-02-23 | AA | accounts | Accounts with accounts type full | |
| 2021-12-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-05-26 | AA | accounts | Accounts with accounts type full | |
| 2021-01-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2020-02-20 | AA | accounts | Accounts with accounts type full | |
| 2019-12-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2019-02-15 | AA | accounts | Accounts with accounts type full | |
| 2019-01-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2018-02-16 | AA | accounts | Accounts with accounts type full | |
| 2018-01-30 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-05-31 vs 2024-05-31
-
Turnover
+8.5%
£42,124,318 £45,713,215
highest in 6 filed years
-
Cash
+1.6%
£6,427,385 £6,527,581
-
Net assets
+5.6%
£42,264,633 £44,643,550
highest in 6 filed years
-
Employees
+1.8%
168 171
highest in 6 filed years
-
Operating profit
+60.8%
£1,345,742 £2,164,066
-
Profit before tax
+66.4%
£1,429,801 £2,378,917
highest in 6 filed years
-
Wages
+5.8%
£9,256,237 £9,792,843
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers